Total RNA of tadpole and frog (Rana catesbeiana) liver was isolated by either 7 or 8 M guanidine-HCI extraction and translated in a cell-free protein-synthesizing system derived from rabbit reticulocytes. The identity of carbamyl phosphate synthetase I [carbamoyl-phosphate synthase (ammonia); ATP:carbamate phosphotransferase (dephosphorylating), EC 2.7.2.5] synthesized in vitro with the purified enzyme was established as follows: (i) immunoprecipitation by a specific antibody; (ii) comigration with purified carrier enzyme on sodium dodecyl sulfate/polyacrylamide gel electrophoresis; (iii) copurification with carrier enzyme by affinity chromatography on Cibacron Blue F3GA-coupled agarose; and (iv) formation of identical proteolytic cleavage products. Inclusion of protease inhibitors in the system resulted in no apparent change in the polypeptide molecular weight. These results indicate that carbamyl phosphate synthetase I is synthesized as a polypeptide that isindistinguishable from the mature enzyme by the analytical methods used and that it is not grossly modified during its transport into mitochondria. The level of translatable mRNA for carbamyl phosphate synthetase-I in tadpole liver was increased about 2-fold 1 day after thyroxine treatment and did not change significantly through 4 subsequent days of treatment. Thus the thyroxine-induced synthesis of carbamyl phosphate synthetase I in tadpole liver is at least partly due to an increase of translatable mRNA for this enzyme.
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Frog liver carbamyl phosphate synthetase I (CPS-I) [carbamoyl-phosphate synthase (ammonia); ATP:carbamate phosphotransferase (dephosphorylating), EC 2.7.2.51, the enzyme involved in the initial step of urea biosynthesis, has a Mr of 320,000 and consists of two identical subunits of Mr 160,000 (1) (2) (3) (4) . It is located in the mitochondrial matrix and constitutes about 20% of the total matrix protein of adult frog liver (5) . The enzyme is synthesized extramitochondrially and is subsequently transported into mitochondria (5) . Previous reports from this laboratory (6, 7) suggested the existence of a macromolecular enzyme precursor that is poorly reactive to the antibody against the mitochondrial CPS-I. However, further attempts to demonstrate a precursor have been unsuccessful (unpublished results). These included the administration to thyroxine (T4)-treated tadpoles of various drugs that would be expected to inhibit mitochondrial accumulation of CPS-I, such as chloramphenicol, ethidium bromide, allylisopropylacetamide (8) , and microbial protease inhibitors (9) . Furthermore, in labeling experiments with tadpole liver slices, the label appeared rapidly in the mitochondrial CPS-I, indicating rapid transport from ribosomes to mitochondrial matrix (unpublished experiments).
In order to clarify this problem, cell-free translation of CPS-I mRNA was undertaken. Studies on tadpole and frog liver mRNA have been hampered by high levels of ribonuclease activities (10) (11) (12) . We modified an extraction method using guanidine-HCl (13) for the isolation of RNA from tadpole and frog liver that was suitable for cell-free translation. The present paper reports the translation in vitro of CPS-I mRNA from tadpole and frog liver to produce a polypeptide that is apparently identical to the subunit of the mature enzyme. This report also deals with the induction of translatable CPS-I mRNA during T4-induced CPS-I synthesis. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. equal volume of ethanol was added to the aqueous layer and the solution was kept at -20C for 20 min. The precipitated RNA was collected by centrifugation and washed twice with 66% (vol/vol) ethanol/0.1 M NaOAc (pH 5.0) and once with ethanol. The RNA was then dried under reduced pressure and stored at -80'C. Method B. RNA was prepared as in method A, except that 8 M guanidine-HCl was used. After the final ethanol precipitation step, the RNA was dissolved in a minimal volume of 20 mM Na2EDTA (pH 7.0 at 4 C), followed by addition of an equal volume of 6 M NaOAc, pH 5.2. After storage at -20'C for 20 min, RNA was collected by centrifugation.
MATERIALS AND METHODS
Precipitation from 3 M NaOAc was repeated once. Final washing and drying of RNA was performed as in method A. Method A permitted significantly better differential precipitation of RNA and protein in the initial ethanol treatment steps.
Analysis of RNA. Integrity of the RNA preparations was evaluated by electrophoresis in polyacrylamide gels containing formamide (15), followed by staining with Stains-All (Eastman) (16) . Only those RNA preparations yielding sharp 18S and 28S ribosomal RNA bands in the absence of low Mr degradation products were used for translation assays. RNA was estimated by using an extinction coefficient at 260 nm of 20 cm-' ml mg'.
Cell-Free Translation. RNA was translated by using a commercial cell-free system derived from rabbit reticulocytes in accordance with the protocol provided (New England Nuclear, catalog no. NEK-001). Incubation was at 370C or 250C in either a 25-or a 50-1d system. Incorporation of [s5S]methionine into protein was determined. Each experiment included as a blank the complete reaction mixture without added RNA.
Antibody Preparation. Frog liver CPS-I was purified to homogeneity by affinity chromatography with Affi-Gel Blue (Cibacron Blue F3GA-coupled agarose, Bio-Rad) (4). Antibody against frog liver CPS-I was produced in rabbits and partially purified by (NH4)2SO4 precipitation (17) .
Analysis of In Vitro Translation Products. After cell-free translation, the reaction mixture was brought to 0.5 ml by the addition of 17 
RESULTS
Total RNA was successfully isolated from tadpole and frog liver by either 7 or 8 M guanidine-HCl extraction. The incorporation of [a5S]methionine into total protein increased as a function of the amount of RNA added to the protein-synthesizing system up to 10 ,tg/25 ,ul and then decreased with higher amounts of RNA. Total protein synthesis at 37°C increased up to 30 min and then slightly decreased by 60 min. When assayed at 25°C, protein synthesis proceeded at a slower rate and reached a higher level than at 37°C. Large polypeptides of Mr up to about 140,000 were synthesized by using control mRNA isolated from adenovirus-infected-HeLa cells (Fig. 1, lane 1) . The total translation products of RNA from T4-treated tadpole liver included a faint band at the position corresponding to the CPS-I subunit (Fig. 1, lane 2) . A similar band was observed with liver RNA of adult frog (Fig. 1, lane 3) .
Immunoprecipitation of the incubation mixture with antibody to frog liver CPS-I and analysis of the immunoprecipitate on NaDodSO4/polyacrylamide gels gave the result shown in Fig. 2A . The major band of radioactivity was associated with a peptide of Mr 160,000 that comigrated with carrier CPS-I. A control experiment, in which bovine liver ornithine transcarbamylase (EC 2.1.3.3) and antibody against that enzyme were added instead of carrier CPS-I and CPS-I antibody, showed no band of radioactivity at the position corresponding to CPS-I. Identification of. the newly synthesized peptide as Translation was carried out at 370C for 60 min in a volume of 25 JAI with adenovirus-infected HeLa cell mRNA (lane 1), 10 ,tg of total RNA of T4-treated (4 days) tadpole liver (lane 2), or 10 ;ig of total RNA of frog liver (lane 3). RNA was isolated by method A. The proteins synthesized weie precipitated by acetone, solubilized by heating in NaDodSO4 sample buffer, and analyzed by NaDodSO4/10% polyacrylamide gel electrophoresis followed by fluorography. Migration is toward the bottom of the figure. 25 Asl with 10 jug of RNA prepared by method A from T4-treated (4 days) tadpoles. To the 105,000 X g supernatant of the reaction mixture was added 10 jg of purified frog liver CPS-I (A and B) or an extract of crude mitochondrial fraction from frog liver containing about 10 ,ug of endogenous CPS-I (C). In B, supernatant supplemented with purified CPS-I was applied to a column (0.5 X 1.0 cm) of Affi-Gel Blue and CPS-I was eluted by Mg2+-free buffer (4) . Immunoprecipitation was performed in the presence (A and B) and absence (C) of the protease inhibitors. The immunoprecipitate was run on a 6% (A and B) or 5% (C) polyacrylamide/NaDodSO4 gel and the gel was stained and fluorographed. Al and Cl, stain; A2, B, and C2, fluorography.
H and L are heavy and light chains, respectively, of immunoglobulin; F is the proteolytic fragment of CPS-I.
CPS-I was further confirmed by copurification with the authentic enzyme by affinity chromatography on Affi-Gel Blue; it was adsorbed to the gel at pH 8.3 in the presence of 5 mM Mg2+ and eluted by a Mg2+-free buffer (4) (Fig. 2B) . We have previously shown that frog CPS-I is cleaved to a fragment of Mr 139,000 by a protease that is present in a crude mitochondrial fraction of frog liver, and the fragment is fully reactive with antibody against the native enzyme (4). Fig. 2C2 , band F, shows that the radioactive product synthesized in vitro was cleaved by the protease in the same manner as the authentic enzyme.
The level of CPS-I synthesis showed a dependence on added RNA similar to that seen for total incorporation, but reached a maximal value at a lower amount of added RNA (5 ,ug/25 Al) (Fig. 3, lanes 1-5) . Inclusion of protease inhibitors resulted in less radioactivity in the lower Mr region of the NaDodSO4 gels, suggesting that the protease inhibitors are effective in preventing premature termination or endogenous proteolysis of CPS-I during translation in vitro (Fig. 3, lane 6) . Preliminary experiments with avian mRNAs in this system indicate that these antiproteases can also selectively alter the translational efficiency of specific mRNAs (unpublished experiments). However, addition of the protease inhibitors resulted in no apparent change in the molecular weight of CPS-I synthesized in vitro.
The synthesis of CPS-I increases severalfold in tadpole liver during a few days of immersion in dilute T4 solution after injection of T4 (21, 22) . In order to see whether the enzyme induction was due to corresponding increases in amoust of translatable mRNA for CPS-I, liver RNA isolated from tadpoles treated with T4 for various periods was translated and the immunoprecipitates were analyzed by NaDodSO4/polyacrylamide gel electrophoresis followed by fluorography (Fig. 4) . While synthesis of CPS-I was seen with RNA from untreated tadpoles, there was an approximately 2-fold increase after T4 treatment for 1 day; synthesis did not increase further after 4 days of treatment and was essentially equivalent to that seen with frog liver RNA. For quantitation, the gels were sliced, solubilized, and assayed for radioactivity ( than 2000 daltons, the possibility cannot be excluded that a "pre-CPS-I" is initially synthesized containing a "signal" peptide of less than 2000 daltons that is cleaved off in conjunction with its transport into the mitochondrion, analogous to the processing of the extramitochondrially synthesized subunits of yeast F1-ATPase (23) .
The incorporation into CPS-I in the translation assays, relative to total incorporation, ranged from approximately 0.003 to 0.01%. The percentage incorporation levels for CPS-I reported here undoubtedly underestimate the actual amount of mRNA for CPS-I within the total mRNA population because the translation assay only scores intact mRNA for CPS-I, and optimal conditions for translation of mRNA for CPS-I in this system have not yet been achieved. Although the assay conditions used were sufficient to determine relative changes in levels of mRNA for CPS-I, further studies using more highly purified mRNA preparations and optimal translation conditions will be required for quantitative correlations of CPS-I and mRNA levels.
The marked increase in CPS-I during the early stages of T4-induced metamorphosis (24) as a result of increased de novo synthesis (6, 7, 22, 25, 26) raises the question as to the primary regulatory mechanism involved. The present study indicates that regulation of the rate of CPS-I synthesis by T4 is determined by the level of mRNA for the enzyme, strongly suggesting that this regulation occurs, at least in part, at the transcriptional level. Additional supporting evidence for this interpretation is provided from the following earlier findings: inhibition of CPS-I induction by actinomycin D (21) ; increased chromatin template capacity in vitro (27) ; increased histone acetylation (28, 29) and phosphorylation (30, 31) ; increased RNA polymerase activities (32, 33) ; and changes in RNA profiles associated with synthesis of CPS-I (10, 34 
